These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21603315)

  • 1. Optical mammography: Diffuse optical imaging of breast cancer.
    Lee K
    World J Clin Oncol; 2011 Jan; 2(1):64-72. PubMed ID: 21603315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer screening with digital mammography for women at average risk for breast cancer, magnetic resonance imaging (MRI) for women at high risk: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(3):1-55. PubMed ID: 23074406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the future of diffuse optical imaging technologies for breast cancer management.
    Tromberg BJ; Pogue BW; Paulsen KD; Yodh AG; Boas DA; Cerussi AE
    Med Phys; 2008 Jun; 35(6):2443-51. PubMed ID: 18649477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse optical imaging of the healthy and diseased breast: a systematic review.
    Leff DR; Warren OJ; Enfield LC; Gibson A; Athanasiou T; Patten DK; Hebden J; Yang GZ; Darzi A
    Breast Cancer Res Treat; 2008 Mar; 108(1):9-22. PubMed ID: 17468951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring the response to primary medical therapy for breast cancer using three- dimensional time-resolved optical mammography.
    Enfield LC; Cantanhede G; Westbroek D; Douek M; Purushotham AD; Hebden JC; Gibson AP
    Technol Cancer Res Treat; 2011 Dec; 10(6):533-47. PubMed ID: 22066594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optical imaging for breast cancer prescreening.
    Godavarty A; Rodriguez S; Jung YJ; Gonzalez S
    Breast Cancer (Dove Med Press); 2015; 7():193-209. PubMed ID: 26229503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review of optical breast imaging and spectroscopy.
    Grosenick D; Rinneberg H; Cubeddu R; Taroni P
    J Biomed Opt; 2016 Sep; 21(9):091311. PubMed ID: 27403837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of various modalities in breast imaging.
    Prasad SN; Houserkova D
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2007 Dec; 151(2):209-18. PubMed ID: 18345253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards non-invasive characterization of breast cancer and cancer metabolism with diffuse optics.
    Busch DR; Choe R; Durduran T; Yodh AG
    PET Clin; 2013 Jul; 8(3):. PubMed ID: 24244206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic review of the effects of diffuse optical imaging in breast diseases.
    Akbari Sari A; Mobinizadeh M; Azadbakht M
    Iran J Cancer Prev; 2013; 6(1):44-51. PubMed ID: 25250109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging in breast cancer: diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy.
    Tromberg BJ; Cerussi A; Shah N; Compton M; Durkin A; Hsiang D; Butler J; Mehta R
    Breast Cancer Res; 2005; 7(6):279-85. PubMed ID: 16457705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near-infrared imaging of the breast using omocianine as a fluorescent dye: results of a placebo-controlled, clinical, multicenter trial.
    Poellinger A; Persigehl T; Mahler M; Bahner M; Ponder SL; Diekmann F; Bremer C; Moesta T
    Invest Radiol; 2011 Nov; 46(11):697-704. PubMed ID: 21788905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging modalities in breast cancer imaging.
    Aminololama-Shakeri S; Khatri VP
    Surg Oncol Clin N Am; 2014 Oct; 23(4):735-49. PubMed ID: 25246048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse near-infrared imaging of tissue with picosecond time resolution.
    Grosenick D; Wabnitz H; Macdonald R
    Biomed Tech (Berl); 2018 Oct; 63(5):511-518. PubMed ID: 29494335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for breast cancer.
    Elmore JG; Armstrong K; Lehman CD; Fletcher SW
    JAMA; 2005 Mar; 293(10):1245-56. PubMed ID: 15755947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening breast magnetic resonance imaging in women with hormone replacement therapy.
    Zhang F; Feng Q; Zhang Z; Hu Y; Zhang Z
    Eur J Med Res; 2018 Oct; 23(1):48. PubMed ID: 30342556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporating new imaging models in breast cancer management.
    Reddy DH; Mendelson EB
    Curr Treat Options Oncol; 2005 Mar; 6(2):135-45. PubMed ID: 15717995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of diffuse optical tomography, ultrasound elastography and mammography in the diagnosis of breast tumors.
    Zhang H; Qin D; Yang Z; Wang K; Sun F; Li B; Cui G
    Ultrasound Med Biol; 2014 Jan; 40(1):1-10. PubMed ID: 24210860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging techniques and molecular imaging in breast cancer.
    Yang WT
    Semin Ultrasound CT MR; 2011 Aug; 32(4):288-99. PubMed ID: 21782119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Issues in breast cancer screening.
    Pisano E
    Technol Cancer Res Treat; 2005 Feb; 4(1):5-9. PubMed ID: 15649082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.